Skip to main content

International Journal of Hematology

Ausgabe 3/2015

Inhalt (20 Artikel)

Images in Hematology

B lymphoblastic leukemia with granules mimicking acute myeloid leukemia

Joo Y. Song, Elham Vali Khojeini, Denis M. Dwyre, Brian A. Jonas

Original Article

High frequency of decreased antithrombin level in pregnant women with thrombosis

Yuki Kamimoto, Hideo Wada, Makoto Ikejiri, Kaname Nakatani, Takashi Sugiyama, Kazuhiro Osato, Nao Murabayashi, Norikazu Yamada, Takeshi Matsumoto, Kohshi Ohishi, Hidehiro Ishikawa, Hidekazu Tomimoto, Masaaki Ito, Tomoaki Ikeda

Original Article

Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim

Douglas B. Cines, Terry Gernsheimer, Jeffrey Wasser, Bertrand Godeau, Drew Provan, Roger Lyons, Ivy Altomare, Xuena Wang, Angela Lopez

Original Article

Silent venous thromboembolism in multiple myeloma patients treated with lenalidomide

Atsushi Isoda, Naru Sato, Yuri Miyazawa, Yoshinobu Matsumoto, Mina Koumoto, Masahito Ookawa, Morio Sawamura, Morio Matsumoto

Original Article

Functional abnormalities and changes in gene expression in fibroblasts and macrophages from the bone marrow of patients with acute myeloid leukemia

Yu Li, Jan Dürig, Maria Göbel, Maher Hanoun, Ludger Klein-Hitpaß, Ulrich Dührsen

Original Article

Serum level of miR-10-5p as a prognostic biomarker for acute myeloid leukemia

Yongjin Zhi, Xiaobao Xie, Rong Wang, Biao Wang, Weiying Gu, Yun Ling, Weimin Dong, Feng Zhi, Yan Liu

Original Article

A new diagnostic kit, ODK-1201, for the quantitation of low major BCR-ABL mRNA level in chronic myeloid leukemia: correlation of quantitation with major BCR-ABL mRNA kits

Hirohisa Nakamae, Chikashi Yoshida, Yasuhiko Miyata, Michihiro Hidaka, Naokuni Uike, Daisuke Koga, Takayuki Sogabe, Itaru Matsumura, Yuzuru Kanakura, Tomoki Naoe

Original Article

Adiponectin is down-regulated in bone marrow interstitial fluid in hematological malignancy

Fan-Yu Lin, Hung-Chang Wu, Kuo-Chen Cheng, Chao-Ling Tung, Chi-Pei Chang, Yin-Hsun Feng

Original Article

Outcome of adolescent patients with acute myeloid leukemia treated with pediatric protocols

Daisuke Tomizawa, Tomoyuki Watanabe, Ryoji Hanada, Keizo Horibe, Yasuo Horikoshi, Shotaro Iwamoto, Akitoshi Kinoshita, Hiroshi Moritake, Hideki Nakayama, Akira Shimada, Takashi Taga, Hiroyuki Takahashi, Akio Tawa, Kiminori Terui, Hiroki Hori, Yoshifumi Kawano, Atsushi Kikuta, Atsushi Manabe, Souichi Adachi

Original Article

Effects of indoleamine 2,3-dioxygenase inhibitor in non-Hodgkin lymphoma model mice

Nobuhiko Nakamura, Takeshi Hara, Masahito Shimizu, Ryoko Mabuchi, Junji Nagano, Tomohiko Ohno, Takahiro Kochi, Masaya Kubota, Yohei Shirakami, Naoe Goto, Hiroyasu Ito, Kuniaki Saito, Takuji Tanaka, Hisataka Moriwaki, Hisashi Tsurumi

Original Article

Evaluation of a novel multiplex RT-qPCR assay for the quantification of leukemia-associated BCR-ABL1 translocation

D. Kottwitz, H. EL Hadi, M. El Amrani, S. Cabezas, H. Dehbi, S. Nadifi, A. Quessar, D. Colomer, Abdeladim Moumen, EL Hassan Sefrioui

Original Article

Unfavorable outcome of chronic myelogenous leukemia in adolescent and young adults treated with tyrosine kinase inhibitors

Masatoshi Sakurai, Takehiko Mori, Daiki Karigane, Keiichi Tozawa, Eri Matsuki, Takayuki Shimizu, Kenji Yokoyama, Hideaki Nakajima, Yoshinobu Kanda, Shinichiro Okamoto

Original Article

Analysis of the molecular mechanism underlying bone marrow necrosis with acute lymphoblastic leukemia

Hiroshi Moritake, Megumi Obara, Naoki Sameshima, Yujiro Asada, Hiroyuki Komatsu, Nobuyuki Hyakuna, Kanji Sugita, Yasushi Ishida, Motohiro Kato, Akihiko Tanizawa, Takao Deguchi, Toshihiko Imamura, Akira Kitanaka, Kazuya Shimoda, Sachiyo Kamimura, Hiroyuki Nunoi

Original Article

The efficacy of prophylactic azithromycin on bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation

Kyung-Wook Jo, Shinkyo Yoon, Jin Woo Song, Tae Sun Shim, Sei Won Lee, Jae Seung Lee, Dae-Young Kim, Je-Hwan Lee, Jung-Hee Lee, Yunsuk Choi, Kyoo-Hyung Lee

Original Article

The use of hyperbaric oxygen therapy in the treatment of hemorrhagic cystitis after allogeneic stem cell transplantation from an unrelated donor

Donata Urbaniak-Kujda, Katarzyna Kapelko-Słowik, Monika Biernat, Jarosław Dybko, Magdalena Laszkowska, Kazimierz Kuliczkowski

Original Article

Immunosuppressive properties of Wharton’s jelly-derived mesenchymal stromal cells in vitro

Haiping He, Tokiko Nagamura-Inoue, Atsuko Takahashi, Yuka Mori, Yuki Yamamoto, Takahisa Shimazu, Hajime Tsunoda, Arinobu Tojo

Case Report

Reactivation of resolved infection with the hepatitis B virus immune escape mutant G145R during dasatinib treatment for chronic myeloid leukemia

Toshihiko Ando, Kensuke Kojima, Hiroshi Isoda, Yuichiro Eguchi, Takashi Honda, Masatoshi Ishigami, Shinya Kimura

Case Report

Myelodysplastic syndrome with t(9;22)(p24;q11.2), a BCR-JAK2 fusion: case report and review of the literature

Bulent Kantarcioglu, Isik Kaygusuz-Atagunduz, Ant Uzay, Tayfur Toptas, Tulin Firatli Tuglular, Mahmut Bayik

Erratum

Erratum to: Bone geometry, bone mineral density, and micro-architecture in patients with myelofibrosis: a cross-sectional study using DXA, HR-pQCT, and bone turnover markers

Sarah Farmer, Hanne Vestergaard, Stinus Hansen, Vikram Vinod Shanbhogue, Claudia Irene Stahlberg, Anne Pernille Hermann, Henrik Frederiksen

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.